PAVmed (PAVM) EBIT Growth (5y) (2021 - 2026)
PAVmed (PAVM) EBIT Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.77 Bn | 194.17 Bn | 7.27 Bn |
| 2 | Stryker | 126.93 Bn | 123.46 Bn | 4.50 Bn |
| 3 | Medtronic | 118.80 Bn | 109.58 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.18 Bn | 72.64 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.40 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.79 Bn | 31.69 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.03 Bn | 22.55 Bn | 684.20 Mn |
| 10 | PAVmed | 32.48 Mn | 28.69 Mn | -89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.55% |
| Dec 31, 2025 | 2.08% |
| Sep 30, 2025 | 2.61% |
| Jun 30, 2025 | 1.22% |
| Mar 31, 2025 | -0.72% |
| Dec 31, 2024 | -2.48% |
| Jun 30, 2024 | -32.75% |
| Mar 31, 2024 | -34.88% |
| Dec 31, 2023 | -37.68% |
| Sep 30, 2023 | -43.31% |
| Jun 30, 2023 | -43.19% |
| Mar 31, 2023 | -60.03% |
| Dec 31, 2022 | -67.10% |
| Sep 30, 2022 | -64.03% |
| Jun 30, 2022 | -63.31% |
| Mar 31, 2022 | -55.55% |
| Dec 31, 2021 | -63.00% |
| Sep 30, 2021 | -47.94% |
| Jun 30, 2021 | -58.06% |
| Mar 31, 2021 | -63.24% |